Prenetics Global divests ACT Genomics for $46M
Source: SeekingAlpha
2025-06-18 08:01:21 ET
More on Prenetics Global
- Seeking Alpha’s Quant Rating on Prenetics Global
- Historical earnings data for Prenetics Global
- Financial information for Prenetics Global
Read the full article on Seeking Alpha
For further details see:
Prenetics Global divests ACT Genomics for $46M
Prenetics Global Limited
NASDAQ: PRE
PRE Trading
20.3% G/L:
$17.72 Last:
220,858 Volume:
$16.50 Open:
PRE Latest News
June 26, 2025 04:30:00 am
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder
June 18, 2025 04:05:00 pm
Crypto Market Recap: Institutional Investments, Stablecoin News and ETF Activity
June 18, 2025 08:45:00 am
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
June 18, 2025 07:50:51 am
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
PRE Stock Data
$277,558,625
10,562,738
N/A
8
N/A
Medical Diagnostics & Screening
Healthcare
HK
Hong Kong
